• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Partial purification and characterization of a cytotoxin from Clostridium difficile.

作者信息

Taylor N S, Bartlett J G

出版信息

Rev Infect Dis. 1979 Mar-Apr;1(2):379-85. doi: 10.1093/clinids/1.2.379.

DOI:10.1093/clinids/1.2.379
PMID:549189
Abstract

A trypsin-sensitive, heat-labile cytotoxin was purified from the supernatant of a culture of Clostridium difficile by a procedure that included ultrafiltration, precipitation with (NH4)2SO4, gel filtration, and ion-exchange chromatography. The procedure resulted in recovery of 20% of the cytotoxin and an estimated 1,500-fold increase in cytotoxic activity. The minimal amount of protein required to give an actinomorphic response in WI-38 cell cultures was 1.4 ng/ml. The estimated molecular weight of the cytotoxin is 240,000. A cytotoxin having similar properties was purified from the stool of a patient with antibiotic-associated pseudomembranous colitis by (NH4)2SO4 precipitation and gel filtration chromatography. This procedure resulted in a recovery of 26% of the cytotoxin, a 50-fold increase in cytotoxic activity, and a cytotoxic response with a minimum of 12.1 ng of protein/ml.

摘要

相似文献

1
Partial purification and characterization of a cytotoxin from Clostridium difficile.
Rev Infect Dis. 1979 Mar-Apr;1(2):379-85. doi: 10.1093/clinids/1.2.379.
2
Antibiotic-associated pseudomembranous colitis.抗生素相关性假膜性结肠炎
Rev Infect Dis. 1979 May-Jun;1(3):530-9. doi: 10.1093/clinids/1.3.530.
3
Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.抗菌药物相关性假膜性结肠炎患者粪便中的艰难梭菌和细胞毒素。
Infection. 1982;10(4):205-8. doi: 10.1007/BF01666910.
4
Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins.
J Infect Dis. 1980 Jan;141(1):92-7. doi: 10.1093/infdis/141.1.92.
5
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.来自不同患者群体的艰难梭菌分离株的分离率和产毒潜力。
Gastroenterology. 1981 Jul;81(1):5-9.
6
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.艰难梭菌及其细胞毒素在抗菌药物相关性腹泻及其他病症患者粪便中的情况。
J Clin Microbiol. 1982 Jun;15(6):1049-53. doi: 10.1128/jcm.15.6.1049-1053.1982.
7
Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.住院患者腹泻粪便中的艰难梭菌及其细胞毒素。分离株的产毒潜力。
Ann Biol Clin (Paris). 1989;47(2):67-70.
8
Antibiotic-associated colitis due to Clostridium difficile in a Kodiak bear.一只科迪亚克棕熊患艰难梭菌所致的抗生素相关性结肠炎
Am J Vet Res. 1983 Aug;44(8):1547-8.
9
Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea.优化住院腹泻患者艰难梭菌细胞毒素检测的临床预测规则。
Am J Med. 1996 May;100(5):487-95. doi: 10.1016/s0002-9343(95)00016-x.
10
Clostridium difficile culture-positive toxin-negative diarrhea.艰难梭菌培养阳性毒素阴性腹泻
Am J Gastroenterol. 1986 Oct;81(10):940-3.

引用本文的文献

1
Management and prevention of recurrent clostridium difficile infection in patients after total joint arthroplasty: a review.全关节置换术后患者复发性艰难梭菌感染的管理与预防:综述
Geriatr Orthop Surg Rehabil. 2012 Dec;3(4):157-63. doi: 10.1177/2151458513479023.
2
Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.经直肠滴注艰难梭菌毒素 A 可引发结肠炎症和组织损伤:艰难梭菌毒素暴露的新型且高效的小鼠模型的建立。
Infect Immun. 2012 Dec;80(12):4474-84. doi: 10.1128/IAI.00933-12. Epub 2012 Oct 8.
3
Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.
综述:艰难梭菌相关性疾病/腹泻与艰难梭菌性结肠炎:一个更具毒性时代的出现
Dig Dis Sci. 2007 Apr;52(4):1071-5. doi: 10.1007/s10620-006-9450-4. Epub 2007 Feb 16.
4
Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.针对毒素A和B的人源单克隆抗体可预防艰难梭菌诱导的仓鼠死亡。
Infect Immun. 2006 Nov;74(11):6339-47. doi: 10.1128/IAI.00982-06. Epub 2006 Sep 11.
5
Clostridium difficile: clinical disease and diagnosis.艰难梭菌:临床疾病与诊断
Clin Microbiol Rev. 1993 Jul;6(3):251-65. doi: 10.1128/CMR.6.3.251.
6
In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis.来自抗生素相关性腹泻或结肠炎患者的艰难梭菌分离株的体外药敏性。
Antimicrob Agents Chemother. 1980 Apr;17(4):695-8. doi: 10.1128/AAC.17.4.695.
7
Clostridium difficile in gnotobiotic mice.悉生小鼠中的艰难梭菌。
Infect Immun. 1980 Apr;28(1):277-82. doi: 10.1128/iai.28.1.277-282.1980.
8
Comparison of two toxins produced by Clostridium difficile.艰难梭菌产生的两种毒素的比较。
Infect Immun. 1981 Dec;34(3):1036-43. doi: 10.1128/iai.34.3.1036-1043.1981.
9
Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis.
Med Microbiol Immunol. 1981;169(3):187-96. doi: 10.1007/BF02123592.
10
Antimicrobial agent-associated colitis and diarrhea.抗菌药物相关性结肠炎和腹泻
West J Med. 1980 Aug;133(2):115-23.